MRK

MERCK & CO INC

MRK·58933Y105·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G

MRK (MERCK & CO INC) is held by 382 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($29.2B), VANGUARD CAPITAL MANAGEMENT LLC ($20.7B), STATE STREET CORP ($15.6B). Net institutional sentiment: Mixed. In Q2 2026, 15 members of Congress and 186 funds bought MRK.

382
Holders
(41 Elite)
$230.3B
Total Value
49% (380)
Consensus
186 buying - 194 selling
13F: Insider & Congress: Updated regularly
MRK

Smart Money Verdict

View all
Loading verdict
Held by 382 funds
41 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Aug 13, 2026 · Activists Apr 30, 2026 · Congress Oct 7, 2026

CongressMaria Elvira SalazarMaria Elvira SalazarSale $1,001 - $15,000Sep 24, 2026
CongressMaria Elvira SalazarMaria Elvira SalazarBuy $15,001 - $50,000Aug 19, 2026
CongressMaria Elvira SalazarMaria Elvira SalazarBuy $15,001 - $50,000Aug 19, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
227M(+0.5%)$29.2B0.4%+37.71%
38
Increased
161.3M(+0.2%)$20.7B0.4%+22.91%
38
Increased
120.4M(+0.9%)$15.6B0.5%+113.73%
38
Increased
86.2M(+2.3%)$11.1B1.9%+65.28%
51
Increased
67.7M(+0.7%)$8.7B0.4%+22.87%
38
Increased
60.7M(+2.0%)$7.8B0.4%+104.57%
39
Increased
54.4M(+9.2%)$7B0.9%+71.88%
49
Increased
48.6M(+2.1%)$6.3B0.3%+27.97%
39
Increased
45.4M(+2.1%)$5.8B0.3%+52.75%
39
Decreased
43.9M(-17.1%)$5.7B0.3%+34.48%
0
Increased
38.5M(+45.7%)$4.9B1.5%+54.71%
68
Decreased
30.5M(-0.8%)$3.9B0.3%+42.49%
0
Decreased
26.3M(-3.0%)$3.4B0.4%+111.12%
0
Increased
22.1M(+9.6%)$2.8B0.2%+54.81%
42
Increased
19.5M(+20.2%)$2.5B0.5%+48.47%
53
Decreased
19.5M(-4.3%)$2.5B0.5%+78.21%
0
Decreased
18.9M(-3.4%)$2.4B0.5%+120.32%
0
Decreased
18.6M(-14.8%)$2.4B0.2%+82.90%
0
Decreased
18.5M(-19.6%)$2.4B0.2%+55.72%
0
Decreased
18.3M(-2.0%)$2.4B0.4%+103.42%
0

Showing 1-20 of 390

1 / 20
MRKMRKMERCK & CO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used